Nikhil C. Munshi

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Nikhil C. Munshi

Mar 15, 2025, 05:17 | Blog

Samer Al Hadidi: Celebrating Bart Barolgie - chair of myeloma research investiture

Samer Al Hadidi, Assistant professor at UAMS Myeloma Center, posted on X: "Great to celebrate…

Nov 25, 2024, 18:11 | Insight

Al-Ola A Abdallah: Early Safety and Efficacy of CAR-T Cell Therapy in Precursor Myeloma

Al-Ola A Abdallah, Plasma Cell Disorder Program Director, Division of HMCT/University of Kansas Medical Center,…

Nov 22, 2024, 11:03 | Insight

Myeloma Paper of the Day, November 22nd, suggested by Robert Orlowski

Robert Orlowski shared a post on X: “Myeloma Paper of the Day: Hyperdiploidy (HD) happens after somatic…

Apr 15, 2024, 12:53 | Opinion

Nikhil C. Munshi: Getting MRD as an endpoint was a great partnership between academia and industry and patient organization

Nikhil C. Munshi, Associate Director of the Jerome Lipper Multiple Myeloma Center at the Dana-Farber…

All: 4 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023